Gufic BioSciences Ltd

NSE
GUFICBIO •
BUY

1W Return

-%

1M Return

-%

6M Return

-%

1Y Return

-%

3Y Return

-%

Start SIP in Gufic BioSciences Ltd
Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
77.34% Gain from 52W Low
5.1
TTM PE Ratio
Below industry Median
37.5
Price to Book Ratio
High in industry
9.1
Dividend yield 1yr %
0.03
TTM PEG Ratio
PEG TTM is much higher than 1
13.2
RSI
RSI is mid-range
42.6
MFI
MFI is mid-range
44.5

Gufic BioSciences Ltd shareholding Pattern

Promoter
72.5%
Foreign Institutions
0.5%
Mutual Funds
1.6%
Domestic Institutions
1.7%
Public
25.3%

Gufic BioSciences Ltd Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
5
Bearish Moving Averages
11
5Day EMA
315.20
10Day EMA
318.30
12Day EMA
319.60
20Day EMA
323.60
26Day EMA
325.20
50Day EMA
324.50
100Day EMA
312.50
200Day EMA
288.90
Delivery & Volume
Resistance & Support
312.50
Pivot
Resistance
First Resistance
320.45
Second Resistance
325.85
Third Resistance
333.80
Support
First Support
307.10
Second support
299.15
Third Support
293.75
Relative Strength Index
42.55
Money Flow Index
44.47
MACD
-5.58
MACD Signal
-3.96
Average True Range
12.87
Average Directional Index
14.52
Rate of Change (21)
-10.60
Rate of Change (125)
4.82

Gufic BioSciences Ltd Company background

Founded in: 1984
Managing director: Jayesh P Choksi
Gufic Biosciences (GBL) was incorporated in Jul84. The Company is a result of a reverse merger of itself with Central Finance. The promoters of GBL took over Central Finance at Rs 4042 per share and then got GBL listed on BSE. Presently, the Company is engaged in the manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals and related services. The Choksi and Gandhi family, the promoters of GBL, have a longstanding presence in the pharma industry. In 1960, the family set up a joint venture company called Lyka Labs. In 1976, they decided to part ways and the Choksi family took over the manufacturing facility and the Gufic group of companies was born. Initially known as Gujarat Fine Chemicals, the first foray of the Gufic group was in the manufacture of various bulk drugs. The company later entered the formulation market. Currently, the overall profile of GBL comprises ethical products, herbal products, consumer products and bulk drugs that are sold in the domestic and the international markets. Over the past several years, the company have a known reputation of creating brands that have vaulted to leadership positions in the category in which they have been marketed. To mention a few names: Shapers (sanitary napkins), Onergy, and Stretch nil.In the year 2000, the company issued Bonus Equity Shares in proportion of five Equity shares for every two Equity shares held.Gufic has divested brands in the ethical pharma business in a sellers market. The company plan to invest further in RD activities and aggressively enter the herbal product and consumer product segments, where it foresee a huge potential. While benefiting from the rich, traditional knowledge base in India, it would like to operate from an area of strength in the herbal products segment.In 202021, Gufic Lifesciences Private Limited amalgamated with the Company through the Scheme of Amalgamation which became effective from May 21, 2021. GUFIC UK LIMITED (GUL), a wholly owned subsidiary of the Company, was incorporated in United Kingdom on March 15, 2022. Similarly, in 2023, Gufic Ireland Limited (GIL) was incorporated on March 02, 2023.
Read More

Gufic BioSciences Ltd FAQs

Gufic BioSciences Ltd shares are currently priced at 315.05 on NSE and 315 on BSE as of 2/28/2024 12:00:00 AM. Please be aware that stock prices are subject to continuous fluctuations due to various factors.

The past 1-year return of Gufic BioSciences Ltd [GUFICBIO] share was 48.57. The Gufic BioSciences Ltd [GUFICBIO] share hit a 1-year low of Rs. 177.65 and a 1-year high of Rs. 364.9.

The market cap of Gufic BioSciences Ltd is Rs. 3159.24 Cr. as of 2/28/2024 12:00:00 AM.

The PE ratios of Gufic BioSciences Ltd is 37.5 as of 2/28/2024 12:00:00 AM.

The PB ratios of Gufic BioSciences Ltd is 6.43 as of 2/28/2024 12:00:00 AM

The Mutual Fund Shareholding was 1.6% at the end of 2/28/2024 12:00:00 AM.

You can easily buy Gufic BioSciences Ltd shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Open Demat Account
or Resume your Application
+91 -

personImage